Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 3

    1.

    Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.

    Keating GM.

    Pharmacoeconomics. 2011 Jun;29(6):535-43. doi: 10.2165/11207430-000000000-00000. Review.

    PMID:
    21568358
    [PubMed - indexed for MEDLINE]
    2.

    Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors.

    Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J, Conaghan PG.

    Pharmacoeconomics. 2011 Mar;29(3):225-37. doi: 10.2165/11584200-000000000-00000.

    PMID:
    21062104
    [PubMed - indexed for MEDLINE]
    3.

    Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding.

    Barkun AN, Adam V, Sung JJ, Kuipers EJ, Mössner J, Jensen D, Stuart R, Lau JY, Nauclér E, Kilhamn J, Granstedt H, Liljas B, Lind T.

    Pharmacoeconomics. 2010;28(3):217-30. doi: 10.2165/11531480-000000000-00000.

    PMID:
    20151726
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk